Contract Services Contract Research
Navin Fluorine International Ltd. unveils "Navin Molecular" as the new brand for its innovative CDMO business
The new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions. Firstly, ...
October 17, 2023 | News
WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration
ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...
October 13, 2023 | News
Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma
In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...
October 11, 2023 | News
Emmes acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...
October 06, 2023 | News
WuXi Bio Applauds Amicus on FDA Approval for Pompe Disease Therapy
Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...
October 02, 2023 | News
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticit...
September 27, 2023 | News
Merck to Become First Provider to Offer Fully Integrated mRNA Services
New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...
September 27, 2023 | News
China-Africa medical cooperation broadens under BRI
From there, he can admire the breathtaking views of the sleek, curved structure and the intricately layered sunshade components, showcasing the marvels of ...
September 04, 2023 | News
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it...
June 28, 2023 | News
Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities
What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...
May 17, 2023 | News
Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment
MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...
May 02, 2023 | News
Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia
Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...
April 26, 2023 | News
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer announced that Clev...
April 18, 2023 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
